What is NDC 0832-6020?

0832-6020 is the product NDC for Chlorpromazine Hydrochloride, Chlorpromazine hydrochloride 100 mg/1 tablet, film coated, listed with the FDA by Upsher-Smith Laboratories, LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.

Upsher-Smith Laboratories, LLC, NDC labeler code 0832. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Chlorpromazine Hydrochloride?

106 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Chlorpromazine Hydrochloride NDC 0832-6020

NDC codes

FDA NDC Directory

Product NDC (as listed)0832-6020Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00832-6020Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
0832-6020-00	0083260200000832602000	100 TABLET, FILM COATED in 1 BOTTLE (0832-6020-00)Marketed from Aug 6, 2021
0832-6020-01	0083260200100832602001	1 BLISTER PACK in 1 CARTON (0832-6020-01) / 100 TABLET, FILM COATED in 1 BLISTER PACK (0832-6020-89)Marketed from Aug 6, 2021
0832-6020-10	0083260201000832602010	1000 TABLET, FILM COATED in 1 BOTTLE (0832-6020-10)Marketed from Aug 6, 2021

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Chlorpromazine Hydrochloride
Generic name (nonproprietary): chlorpromazine hydrochloride
Active ingredients: Chlorpromazine hydrochloride — 100 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Upsher-Smith Laboratories, LLCNDC labeler code 0832
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 084114
Marketing start: Aug 3, 2011
Listing expires: Dec 31, 2027
Other FDA classes: Phenothiazines (Chemical structure)
Identifiers: Product ID 0832-6020_787f32b3-e4f6-424d-a2c0-d249b5bbcd93SPL ID 787f32b3-e4f6-424d-a2c0-d249b5bbcd93SPL set ID 5ae79c1e-f523-4358-9f8b-7382a03d59bcRxCUI 991039, 991044, 991188, 991194, 991336UNII 9WP59609J6UPC 0308326020000, 0308326018007, 0308326021007, 0308326017000, 0308326019004
Pharmacologic class: Phenothiazine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400832602000 followed by a unit qualifier and the quantity

Package 00832-6020-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 13, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE For the management of manifestations of psychotic disorders. For the treatment of schizophrenia. To control nausea and vomiting. For relief of restlessness and apprehension before surgery. For acute intermittent porphyria. As an adjunct in the treatment of tetanus. To control the manifestations of the manic type of manic-depressive illness. For relief of intractable hiccups. For the treatment of severe behavioral problems in children (1 to 12 years of age) marked by combativeness and/or explosive hyperexcitable behavior (out of proportion to immediate provocations), and in the short-term treatment of hyperactive children who show excessive motor activity with accompanyi…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0832-6020

What is NDC 0832-6020?: 0832-6020 is the product NDC for Chlorpromazine Hydrochloride, Chlorpromazine hydrochloride 100 mg/1 tablet, film coated, listed with the FDA by Upsher-Smith Laboratories, LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Chlorpromazine Hydrochloride.
What is the active ingredient?: Chlorpromazine hydrochloride.
Who is the labeler?: Upsher-Smith Laboratories, LLC, NDC labeler code 0832. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Chlorpromazine Hydrochloride?: 106 other product NDCs are listed under this name. See all Chlorpromazine Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Chlorpromazine Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Chlorpromazine Hydrochloride	Chlorpromazine hydrochloride 25 mg/1	Tablet, Sugar coatedOral	American Health Packaging	60687-938	60687-0938-0160687-0938-65
Chlorpromazine Hydrochloride	Chlorpromazine hydrochloride 50 mg/1	Tablet, Sugar coatedOral	American Health Packaging	60687-949	60687-0949-01
Chlorpromazine Hydrochloride	Chlorpromazine hydrochloride 100 mg/1	Tablet, Sugar coatedOral	American Health Packaging	60687-960	60687-0960-01
Chlorpromazine Hydrochloride	Chlorpromazine hydrochloride 200 mg/1	Tablet, Sugar coatedOral	American Health Packaging	60687-971	60687-0971-01
Chlorpromazine Hydrochloride	Chlorpromazine hydrochloride 100 mg/mL	ConcentrateOral	Saptalis Pharmaceuticals, LLC.	71656-101	71656-0101-08
Chlorpromazine Hydrochloride	Chlorpromazine hydrochloride 30 mg/mL	ConcentrateOral	Saptalis Pharmaceuticals, LLC.	71656-102	71656-0102-04
Chlorpromazine Hydrochloride	Chlorpromazine hydrochloride 25 mg/mL	InjectionIntramuscular	Novadoz Pharmaceuticals LLC	72205-190	72205-0190-25
Chlorpromazine Hydrochloride	Chlorpromazine hydrochloride 25 mg/mL	InjectionIntramuscular	Novadoz Pharmaceuticals LLC	72205-191	72205-0191-25
Chlorpromazine Hydrochloride	Chlorpromazine hydrochloride 25 mg/1	Tablet, Sugar coatedOral	Coupler LLC	67046-1633	67046-1633-03
chlorpromazine hydrochloride	Chlorpromazine hydrochloride 30 mg/mL	ConcentrateOral	Advagen Pharma Ltd	72888-457	72888-0457-01

All 107 Chlorpromazine Hydrochloride NDCs

Other NDCs under ANDA 084114

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 084114
Product	Strength	Form · route	Labeler	Product NDC
Chlorpromazine Hydrochloride	Chlorpromazine hydrochloride 100 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4294